Aristea Therapeutics Funding: $205M Raised, Series A (2025)
Aristea Therapeutics is based in San Diego, CA. It has raised $205M in total funding. Latest round: Series A.
Aristea Therapeutics funding overview
Aristea Therapeutics is based in San Diego, CA. Aristea Therapeutics has raised $205M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2025. The round record for Aristea Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Novo Holdings, Catalys Pacific, SR One, Lightstone VC, Longwood Fund, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.
Aristea Therapeutics at a glance
Total raised
$205M
Latest round
Series A
Latest round date
June 2025
Headquarters
San Diego, CA
Notable investors
Novo Holdings, Catalys Pacific, SR One, Lightstone VC, Longwood Fund, Alexandria Venture Investments
Frequently asked about Aristea Therapeutics funding
How much has Aristea Therapeutics raised?
Aristea Therapeutics has raised $205M in total disclosed funding across the rounds on record.
Who has invested in Aristea Therapeutics?
Novo Holdings, Catalys Pacific, SR One, Lightstone VC, Longwood Fund, Alexandria Venture Investments are named among the investors backing Aristea Therapeutics.
What was the latest Aristea Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2025.
Where is Aristea Therapeutics based?
Aristea Therapeutics is based in San Diego, CA.
When did Aristea Therapeutics last raise?
The last disclosed Aristea Therapeutics round closed in June 2025 at Series A.
Round data for Aristea Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Diego and backer lists below.
